Sign Up to like & get recommendations! 1
Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31214
Abstract: The association of dietary factors with urinary bladder cancer prognosis has scarcely been investigated, and results of studies conducted to date are inconsistent. We investigated whether empirically derived dietary patterns are associated with risks of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "World Journal of Urology"
DOI: 10.1007/s00345-019-02681-2
Abstract: PurposeRoutine second transurethral resection (TUR) for non-muscle-invasive bladder cancer (NMIBC) is common practice in Germany. Applicability of European Organization for Research and Treatment of Cancer (EORTC) and Spanish Urological Club for Oncological Treatment (CUETO) models… read more here.
Sign Up to like & get recommendations! 3
Published in 2022 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-022-06887-w
Abstract: It is plausible that patients with pancreatic cancer experience fear of tumor recurrence or progression (FOP). The aim of this study was to compare FOP in patients with pancreatic cancer treated with surgical resection, palliative… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "BMC Urology"
DOI: 10.1186/s12894-018-0408-6
Abstract: BackgroundIntravesical Mitomycin-C (MMC) following transurethral resection of bladder tumor (TURBT), while efficacious, is associated with side effects and poor utilization. Continuous saline bladder irrigation (CSBI) has been examined as an alternative. In this study we… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Chinese clinical oncology"
DOI: 10.21037/cco-24-ab022
Abstract: BACKGROUND The initial management of craniopharyngioma is generally either gross total resection (GTR) or subtotal resection (STR) with adjuvant radiotherapy (RT). However, the optimal management strategy for recurrent/progressive craniopharyngioma remains unclear. METHODS PubMed and Embase… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.793337
Abstract: Background Pituitary adenoma (PA) is a benign neuroendocrine tumor caused by adenohypophysial cells, and accounts for 10%-20% of all primary intracranial tumors. The surgical outcomes and prognosis of giant pituitary adenomas measuring ≥3 cm in… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Behavioral Sciences"
DOI: 10.3390/bs15040479
Abstract: Support to manage fear of recurrence and progression (FoRP) is a major concern and a commonly unmet need for people with chronic illness. The current study identified profiles of and risk factors for FoRP in… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Cancer"
DOI: 10.7150/jca.35866
Abstract: We aim to determine clinical recurrence and progression risk factors of T1G3 bladder cancer (BCa), and to establish recurrence and progression prediction models. 5-year follow-up records of 106 T1G3 BCa patients from January 2012 to… read more here.